GlassScriptPhysician profile
Mary Greenwalt
NPI 1417475450
$2,159.98
in general payments reported to CMS, 2019-2025
28 companies · $467 in 2025
The $467 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $160 · 2022: $343 · 2023: $642 · 2024: $548 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,569 · Education: $80.00 · Travel and Lodging: $8.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,568.88 |
| Education | $80.00 |
| Travel and Lodging | $8.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $419.17 | 2021-2023 | Watchman Access System, Eluvia |
| Janssen Pharmaceuticals, INC | $332.85 | 2021-2024 | Xarelto |
| Bsn Medical INC | $166.69 | 2025 | |
| Novartis Pharmaceuticals Corporation | $132.21 | 2023-2025 | |
| Ossur Americas, INC. | $122.76 | 2024-2025 | |
| Angiodynamics, INC. | $118.03 | 2021-2024 | Auryon Laser System 100-120 Vac |
| Shockwave Medical, INC | $90.56 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Endologix LLC | $84.50 | 2024-2025 | Torus Stent Graft System, Endocross Device |
| Tactile Systems Technology INC | $80.00 | 2023 | |
| Amgen INC. | $62.93 | 2023-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $60.91 | 2023-2024 | Wainua, Farxiga, Brilinta |
| Kerecis Limited | $56.31 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Bard Peripheral Vascular, INC. | $45.92 | 2024 | Rotarexs 6 F X 135 Cm, Crosser Iq |
| Lemaitre Vascular, INC. | $45.19 | 2025 | Restoreflow |
| Novo Nordisk INC | $44.07 | 2023 | Ozempic |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $35.67 | 2024-2025 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Lexicon Pharmaceuticals, INC. | $31.91 | 2023 | Inpefa |
| My01 INC. | $29.50 | 2023 | My01 Continuous Compartmental Pressure Monitor |
| Altathera Pharmaceuticals LLC | $29.39 | 2023-2024 | Sotalol Hydrochloride |
| Silk Road Medical, INC. | $28.16 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Imperative Care, INC | $24.35 | 2024 | Prodigy Catheter |
| Esperion Therapeutics, INC. | $20.06 | 2023 | Nexletol |
| Cordis US Corp. | $18.83 | 2023 | Mynxgrip |
| Alnylam Pharmaceuticals INC. | $18.43 | 2023 | Onpattro |
| Scpharmaceuticals INC. | $16.50 | 2023 | |
| Heartflow, INC. | $16.14 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $15.07 | 2024 | Eliquis |
| Chiesi USA, INC. | $13.87 | 2023 | Kengreal, Cleviprex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Greenwalt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.